Junqiang Tian

739 total citations
40 papers, 452 citations indexed

About

Junqiang Tian is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Junqiang Tian has authored 40 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Surgery, 19 papers in Pulmonary and Respiratory Medicine and 10 papers in Oncology. Recurrent topics in Junqiang Tian's work include Bladder and Urothelial Cancer Treatments (16 papers), Ferroptosis and cancer prognosis (10 papers) and Epigenetics and DNA Methylation (6 papers). Junqiang Tian is often cited by papers focused on Bladder and Urothelial Cancer Treatments (16 papers), Ferroptosis and cancer prognosis (10 papers) and Epigenetics and DNA Methylation (6 papers). Junqiang Tian collaborates with scholars based in China and United States. Junqiang Tian's co-authors include Zhiping Wang, Hanzhang Wang, Wan Du, Liyuan Zhang, Jianpeng Li, Xiangxiang Zhang, Dali Han, Hao Wu, Zhiqiang Yao and Xin Yang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Ecotoxicology and Environmental Safety.

In The Last Decade

Junqiang Tian

38 papers receiving 446 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junqiang Tian China 11 136 135 133 107 83 40 452
Arighno Das United States 11 93 0.7× 156 1.2× 100 0.8× 40 0.4× 75 0.9× 26 368
J Dvořáček Czechia 13 84 0.6× 350 2.6× 148 1.1× 64 0.6× 60 0.7× 56 609
Anja Bauerfeind Germany 12 163 1.2× 68 0.5× 147 1.1× 32 0.3× 38 0.5× 28 588
Jung Mi Byun South Korea 13 85 0.6× 59 0.4× 46 0.3× 96 0.9× 83 1.0× 43 466
Dae Hoon Jeong South Korea 13 184 1.4× 55 0.4× 50 0.4× 54 0.5× 128 1.5× 41 464
Patrick Timmins United States 10 79 0.6× 90 0.7× 45 0.3× 86 0.8× 63 0.8× 21 411
Naomi Strubel United States 10 185 1.4× 87 0.6× 56 0.4× 26 0.2× 39 0.5× 20 408
Michael A. Bidus United States 12 89 0.7× 102 0.8× 52 0.4× 177 1.7× 104 1.3× 21 441
Theofano Orfanelli United States 9 103 0.8× 49 0.4× 36 0.3× 42 0.4× 100 1.2× 31 352
Moon Su Sung South Korea 13 61 0.4× 56 0.4× 43 0.3× 74 0.7× 51 0.6× 38 449

Countries citing papers authored by Junqiang Tian

Since Specialization
Citations

This map shows the geographic impact of Junqiang Tian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junqiang Tian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junqiang Tian more than expected).

Fields of papers citing papers by Junqiang Tian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junqiang Tian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junqiang Tian. The network helps show where Junqiang Tian may publish in the future.

Co-authorship network of co-authors of Junqiang Tian

This figure shows the co-authorship network connecting the top 25 collaborators of Junqiang Tian. A scholar is included among the top collaborators of Junqiang Tian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junqiang Tian. Junqiang Tian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Xinyu, Pan Li, Yuanfeng Zhang, et al.. (2025). A machine learning-based prognostic signature utilizing MSC proteomics for predicting bladder cancer prognosis and treatment response. Translational Oncology. 54. 102349–102349.
2.
Gong, Yuwen, Hui Cheng, Junqiang Tian, et al.. (2025). SRC enhanced cisplatin resistance in bladder cancer by reprogramming glycolysis and pentose phosphate pathway. Communications Biology. 8(1). 36–36. 4 indexed citations
3.
Zhang, Xinyu, Yuhan Wang, Junqiang Tian, et al.. (2025). A novel sono-activatable nanoreactor induces precision intratumoral juglone generation and caspase 3/GSDME-mediated pyroptosis for treatment of bladder cancer. Journal of Nanobiotechnology. 23(1). 795–795.
4.
Zhang, Luyang, Hui Ding, Junqiang Tian, et al.. (2024). Risk factors of high fluid absorption in patients treated with mini-PCNL: a single-center prospective study. World Journal of Urology. 42(1). 114–114. 1 indexed citations
5.
Wang, Fang, Shengjun Fu, Junqiang Tian, et al.. (2024). Mesenchymal stem cells in tumor microenvironment: drivers of bladder cancer progression through mitochondrial dynamics and energy production. Cell Death and Disease. 15(9). 688–688. 8 indexed citations
6.
Zhang, Yunxin, Hui Ding, Li Yang, et al.. (2024). Perioperative outcomes and continence following robotic-assisted radical cystectomy with mainz pouch II urinary diversion in patients with bladder cancer. BMC Cancer. 24(1). 127–127. 1 indexed citations
7.
Li, Jianpeng, et al.. (2022). A Bioinformatic Analysis of Immune-Related Prognostic Genes in Clear Cell Renal Cell Carcinoma Based on TCGA and GEO Databases. SHILAP Revista de lepidopterología. 4 indexed citations
8.
Cheng, Hui, et al.. (2022). ADAM12 promotes gemcitabine resistance by activating EGFR signaling pathway and induces EMT in bladder cancer. Clinical & Translational Oncology. 25(5). 1425–1435. 8 indexed citations
9.
Zhang, Tao, Yuwen Gong, Tao Yan, et al.. (2022). Aldehyde dehydrogenase 6 family member A1 negatively regulates cell growth and to cisplatin sensitivity in bladder cancer. Molecular Carcinogenesis. 61(7). 690–701. 7 indexed citations
10.
11.
Zhang, Xiaohua, Xinguo Liu, Jinjun Chen, et al.. (2021). Acupuncture versus Lornoxicam in the Treatment of Acute Renal Colic: A Randomized Controlled Trial. Journal of Pain Research. Volume 14. 3637–3648. 6 indexed citations
12.
Li, Jianpeng, et al.. (2021). Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis. BMC Cancer. 21(1). 858–858. 10 indexed citations
13.
Zhang, Jinghua, Junqiang Tian, Lifeng Li, et al.. (2021). Circulating Tumor DNA Analyses Predict Disease Recurrence in Non-Muscle-Invasive Bladder Cancer. Frontiers in Oncology. 11. 657483–657483. 19 indexed citations
14.
Zhang, Yang, Yufeng Li, Ye Li, et al.. (2020). <p>Testicular Metastasis from Urothelial Carcinoma of the Renal Pelvis: A Rare Case and Review of the Literature</p>. OncoTargets and Therapy. Volume 13. 915–920. 3 indexed citations
15.
Yang, Xin, Jianpeng Li, Hao Wu, et al.. (2020). Screening and Identifying Immune-Related Cells and Genes in the Tumor Microenvironment of Bladder Urothelial Carcinoma: Based on TCGA Database and Bioinformatics. Frontiers in Oncology. 9. 1533–1533. 40 indexed citations
16.
Wu, Hao, et al.. (2020). Tumour-associated macrophages mediate the invasion and metastasis of bladder cancer cells through CXCL8. PeerJ. 8. e8721–e8721. 52 indexed citations
17.
Kong, Weiwei, Fan Liu, Chunxia Liu, et al.. (2019). Effects of multimode analgesia on acute pain after total knee arthroplasty and influence factors. 13(2). 255–260. 2 indexed citations
18.
Cao, Wenjuan, Junqiang Tian, Chong Li, et al.. (2017). A novel bladder cancer - specific oncolytic adenovirus by CD46 and its effect combined with cisplatin against cancer cells of CAR negative expression. Virology Journal. 14(1). 149–149. 5 indexed citations
19.
Wang, Hanzhang, Zhongjin Yue, Li Yang, et al.. (2014). Waist circumference and risk of lower urinary tract symptoms: a meta-analysis. The Aging Male. 17(4). 223–229. 10 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arighno Das Breakdown of academic impact, for papers by J Dvořáček Breakdown of academic impact, for papers by Anja Bauerfeind Breakdown of academic impact, for papers by Jung Mi Byun Breakdown of academic impact, for papers by Dae Hoon Jeong Breakdown of academic impact, for papers by Patrick Timmins Breakdown of academic impact, for papers by Naomi Strubel Breakdown of academic impact, for papers by Michael A. Bidus Breakdown of academic impact, for papers by Theofano Orfanelli Breakdown of academic impact, for papers by Moon Su Sung
Rankless by CCL
2026